Product Image

Melatonin 20 mg

NutriCology
4.4
★ ★ ★ ★ ★
(405 ratings)
Melatonin 20 mg
Product Image
Score63
A very high-dose 20 mg capsule with limited flexibility and weak value. The amount is difficult to support for routine sleep use without a specific supervised reason.
How scoring works
Quantity:60 Capsule(s) • (60 servings)
Goals:
Sleep Support

Score 63

A very high-dose 20 mg capsule with limited flexibility and weak value. The amount is difficult to support for routine sleep use without a specific supervised reason.
How scoring works
$42.59($0.70 per serving)
iHerb
$ 42.59
Pure Formulas
$ 42.59
Amazon
$ 42.59
Report prices

Analysis

The 20 mg capsule delivers a very large melatonin amount in one unit. Although melatonin is relevant to sleep timing, such a high serving may add adverse effects rather than better sleep support.

A standard immediate-release capsule is aimed mainly at sleep onset and does not maintain delivery overnight. No companion ingredients provide relaxation or another meaningful sleep pathway.

The serving is costly compared with many lower-dose options. A fixed 20 mg capsule is also difficult to adjust, so it fits only a narrow use case under informed supervision.

Who is it for
  • Adults specifically directed to use 20 mg
  • Users who have established tolerance under professional guidance
  • People who require a capsule format
Best for
  • Narrow supervised use
  • One-capsule dosing
  • Direct melatonin delivery

Pros

  • Clearly disclosed active amount
  • One capsule per serving
  • Focused single-ingredient formula

Cons

  • Extreme 20 mg serving
  • High cost per use
  • No sustained-release design
  • Poor dosing flexibility

Warnings

  • The 20 mg amount may cause marked morning grogginess, vivid dreams, headache, or daytime sleepiness
  • Use this high amount only when a qualified professional has identified a specific need
  • Do not drive or operate machinery if residual impairment is possible

Nutrient quality

58 Moderate impact

The focused capsule contains no unrelated actives. Extreme potency creates a poor balance for general sleep support.

.

Ingredient transparency

82 Highest impact

Active amounts and the unit serving are clearly disclosed. Complete directions, release details, and inactive ingredients remain absent.

.

Customer satisfaction

67 High impact

Customer sentiment is favorable. A substantial rating base makes the average dependable, while no narrative feedback was supplied.

.

Value for money

38 Lower impact

Serving economics are weak. Quality limitations keep practical value low.

.
Report analysis

Goals

Sleep Support
Impact
Moderate effect
A Goal FitD- Strength of SupportD- CoverageB- Formula Quality
Melatonin · 20 mg

Melatonin is directly tied to sleep timing, but the 20 mg amount is an extreme dose for general sleep support. The single capsule makes the full amount easy to take.

Such high exposure may increase next-day sleepiness, vivid dreams, headache, or disrupted sleep timing. The lack of sustained release or a clear high-need use case makes the formula poorly balanced for routine use.

Study evidence
Melatonin Supportive 181 studies

Ingredients

IngredientAmount per serving
Melatonin
20 mg
Adults 18–50 Women
Report overview
Melatonin · 20 mg OverallScore34
F Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyF Value

The capsule provides straightforward single-unit dosing but uses a very high melatonin amount. That megadose raises the practical risk of next-day sleepiness and offers little alignment with physiological use. The serving is expensive, with no sustained-release technology or independent purity certification disclosed.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Meta-analysis: melatonin for the treatment of primary sleep disorders.
    Ferracioli-Oda E; Qawasmi A; Bloch MH · PloS one · 2013
    Meta-analysis1,683 participants19 studies pooledSleep Support forMelatonin
  2. Melatonin treatment for age-related insomnia.
    Zhdanova IV; Wurtman RJ; Regan MM; Taylor JA; Shi JP; Leclair OU · The Journal of clinical endocrinology and metabolism · 2001
    Randomized trial30 participantsSleep Support forMelatonin
  3. The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
    Yousef O; Abouelmagd ME; Khaddam H; Shbani A; Yousef R; Meshref M; Hanafi I · Journal of sleep research · 2026
    Meta-analysis409 participants8 studies pooledSleep Support forMelatonin
  4. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N · BMC medicine · 2010
    Randomized trial791 participantsSleep Support forMelatonin
  5. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I · Sleep medicine reviews · 2005
    Meta-analysis284 participants8 studies pooledSleep Support forMelatonin